Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT05048719

Public ClinicalTrials.gov record NCT05048719. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 9:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo and Once-Weekly Dulaglutide in Participants With Type 2 Diabetes Mellitus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate the efficacy and safety of LY3502970 in participants with type 2 diabetes (T2D) who failed to achieve adequate glycemic control on diet and exercise alone or on a stable dose of metformin. This study will last about 30 weeks.

Study identification

NCT ID
NCT05048719
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
383 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 15, 2021 (Actual)
Primary completion
Sep 30, 2022 (Actual)
Completion
Sep 30, 2022 (Actual)
Last update posted
Oct 17, 2023

2021 – 2022

United States locations

U.S. sites
20
U.S. states
9
U.S. cities
20
Facility City State ZIP Site status
Anaheim Clinical Trials, LLC Anaheim California 92801 —
Velocity Clinical Research, Huntington Park Huntington Park California 90255 —
Velocity Clinical Research, Westlake Los Angeles California 90057 —
Rancho Cucamonga Clinical Research Rancho Cucamonga California 91730 —
Touro University California Vallejo California 94592 —
New West Physicians Clinical Research Golden Colorado 80401 —
Optumcare Colorado Springs - Monument Monument Colorado 80132 —
Cotton O'Neil Clinical Research Center Topeka Kansas 66606 —
Clinvest Research LLC Springfield Missouri 65807 —
Premier Research Trenton New Jersey 08611 —
Intend Research, LLC Norman Oklahoma 73069 —
Capital Area Research, LLC Camp Hill Pennsylvania 17011 —
Family Medical Associates Levittown Pennsylvania 19056 —
Tristar Clinical Investigations Philadelphia Pennsylvania 19114 —
Dallas Diabetes Research Center Dallas Texas 75230 —
Biopharma Informatic, LLC Houston Texas 77084 —
Bandera Family Health Care San Antonio Texas 78249 —
Consano Clinical Research, LLC Shavano Park Texas 78231 —
Capital Clinical Research Center Olympia Washington 98502 —
Eastside Research Associates Redmond Washington 98052 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05048719, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 17, 2023 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05048719 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →